Home
>
National Drug Code (NDC)
>
GLASSIA
GLASSIA - 0944-2884-01 - (Alpha-1-Proteinase Inhibitor (Human))
Drug Information of GLASSIA
| Product NDC: | 0944-2884 |
| Proprietary Name: | GLASSIA |
| Non Proprietary Name: | Alpha-1-Proteinase Inhibitor (Human) |
| Active Ingredient(s): | 1 g/50mL & nbsp; Alpha-1-Proteinase Inhibitor (Human) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GLASSIA
| Product NDC: | 0944-2884 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125325 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110531 |
Package Information of GLASSIA
| Package NDC: | 0944-2884-01 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (0944-2884-01) > 50 mL in 1 VIAL, GLASS |
NDC Information of GLASSIA
| NDC Code | 0944-2884-01 |
| Proprietary Name | GLASSIA |
| Package Description | 1 VIAL, GLASS in 1 CARTON (0944-2884-01) > 50 mL in 1 VIAL, GLASS |
| Product NDC | 0944-2884 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Alpha-1-Proteinase Inhibitor (Human) |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110531 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
| Strength Number | 1 |
| Strength Unit | g/50mL |
| Pharmaceutical Classes | Human alpha-1 Proteinase Inhibitor [EPC],Trypsin Inhibitors [MoA] |
